Aclaris Therapeutics, Inc.
ACRSNASDAQ
Healthcare
Medical - Diagnostics & Research
$4.16
+0.01(0.4%)
52W $1.08 – $4.53
Quick:
SCHEDULE 13G/A
Mar 26, 2026 (1 weeks ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Mar 11, 2026 (3 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 9, 2026 (4 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 26, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Feb 26, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 9, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Jan 21, 2026 (2 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Jan 9, 2026 (2 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 6, 2026 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 13, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Nov 6, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 6, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 14, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 7, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 7, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G
Jul 29, 2025 (8 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jul 29, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Jul 24, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Jul 17, 2025 (8 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active